|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/70 | |||
| A61P 25/00 | |||
| A61K 9/20 |
| (11) | Patento numeris | 2937083 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15150813.2 |
| Europos patento paraiškos padavimo data | 2010-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 266864 P | 2009-12-04 | US |
| (72) |
Laughlin, Sharon M., US
Sizensky, Michael J., US
Singh, Surendra P., US
Wilkinson, Scott H., US
Huang, Cai Gu, US
Bonasia, Philip James, US
D`Souza, Susan S., US
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | Formulations, salts and polymorphs of transnorsertraline and uses thereof |
| Formulations, salts and polymorphs of transnorsertraline and uses thereof |